Aytu Biopharma Inc (AYTU) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access AYTU Annual Balance Sheets →
The table below presents a historical view of Aytu Biopharma Inc's balance sheet, supporting analysis of financial position trends.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent26.72
Cash & Short-term Investments26.00
Accounts receivable24.49
Inventories7.46
Other Current Assets0.00
Prepaid Expense And Other Assets Current8.66
Total Current Assets67.33
Equipment/Property/Plant Net0.41
Intangible Assets42.49
Other Assets, Noncurrent1.47
Total Assets111.69
Liabilities
Accounts Payable, Current AC13.21
Accrued Liabilities, Current AC34.27
Long-term Debt and Capital Lease Obligations, Current DE1.86
Other Liabilities, Current10.63
Total Current Liabilities59.97
Long-term debt9.55
Total Long-term Debt9.55
Derivative Liability, Noncurrent DE2.18
Total Liabilities76.55
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock382.91
Retained Earnings / Accumulated Deficit-347.77
Other Equity0.00
Common Stockholder's Equity35.14
Total Stockholder's Equity35.14
Liabilities & Stockholder's Equity111.69
4 historic quarters locked

Sign in to unlock the full Aytu Biopharma Inc balance sheet history.

About Aytu Biopharma Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001437749-26-016721

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.